Learn More
By using synthetic oligodeoxynucleotides related to the "-10" regions of spc and lacUV5 E. coli promoters we have shown, that the efficient binding occurs with oligodeoxynucleotides non-transcribed(More)
The use of biomedical SNP markers of diseases can improve effectiveness of treatment. Genotyping of patients with subsequent searching for SNPs more frequent than in norm is the only commonly(More)
Some variations of human genome [for example, single nucleotide polymorphisms (SNPs)] are markers of hereditary diseases and drug responses. Analysis of them can help to improve treatment.(More)